OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis

Introduction The power of ‘real world’ data to improve our understanding of the clinical aspects of multiple sclerosis (MS) is starting to be realised. Disease modifying therapy (DMT) use across the UK is driven by national prescribing guidelines. As such, the UK provides an ideal country in which t...

Cijeli opis

Bibliografski detalji

Glavni autori:	Ana Cavey, Ruth Dobson, Camilla Blain, Richard Nicholas, Jeremy Hobart, David Rog, Monica Marta, Cheryl Hemingway, Nikos Evangelou, Matthew Craner, Paul M Matthews, Neil Scolding, Helen L Ford, Stewart Webb, Ed Waddingham, Aleisha Miller, Carolyn Anne Young
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 2021-11-01
Serija:	BMJ Open
Online pristup:	https://bmjopen.bmj.com/content/11/11/e050176.full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!